On 3 October 2026, Vicky, the Founder and CEO of Vie Aesthetics, will be taking on the Thames Path Challenge — a 21km walk from Hampton Court to the Millennium Bridge — alongside a team of fellow fundraisers. We’ll pass historic parkland and some of London’s most iconic sights along the way. But the real destination isn’t the finish line; it’s what this walk means for three charities close to our heart.
We are raising money for Lady McAdden Breast Cancer Trust, Big Purple Pants, and Bosom Pals Southend — three organisations that support people affected by breast cancer across Essex. This year is especially meaningful, as it marks Lady McAdden’s 50th anniversary.
If you’d like to sponsor this challenge, every donation — however large or small — is shared equally between Lady McAdden Breast Cancer Trust, Big Purple Pants and Bosom Pals Southend, helping all three continue their vital work.
Spending time with clients navigating some of the hardest chapters of their lives teaches you something simple but easy to forget: healthcare isn’t only about medicine. It’s about compassion, community, and being there when people need you most.
“Walking 21km won’t be easy. There will be sore feet, tired legs, and probably a moment or two where I question my life choices. But that discomfort is nothing compared to what the people these charities support face every single day.”
Vicky Grammatikopoulou
Supporting local charities has always mattered to us at Vie. Over the years, our team has taken part in fundraising events including Race for Life as the ‘Vie Ladies’, alongside supporting local schools and community organisations through sponsorship and awareness campaigns. Giving back is simply part of our culture.
And Vicky adds: “As the founder of Vie Aesthetics, I’ve always believed our role goes beyond the treatments we provide. Every day, our team helps clients rebuild confidence and improve their wellbeing — and for many, that includes supporting their skin, hair and wellness during and after cancer treatment, through carefully tailored, medically-led protocols.”
